CompletedPhase 2NCT00000975
A Study of Itraconazole in the Treatment and Prevention of Histoplasmosis, a Fungal Infection, in Patients With AIDS
Studying Histoplasmosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Principal Investigator
- LJ Wheat
- Intervention
- Itraconazole(drug)
- Enrollment
- 30 enrolled
- Eligibility
- 13 years · All sexes
- Timeline
- 1994
Study locations (12)
- USC CRS, Los Angeles, California, United States
- Northwestern University CRS, Chicago, Illinois, United States
- Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis, Indiana, United States
- Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU, New Orleans, Louisiana, United States
- University of Minnesota, ACTU, Minneapolis, Minnesota, United States
- Washington U CRS, St Louis, Missouri, United States
- Cornell University A2201, New York, New York, United States
- Univ. of Rochester ACTG CRS, Rochester, New York, United States
- Duke Univ. Med. Ctr. Adult CRS, Durham, North Carolina, United States
- Univ. of Cincinnati CRS, Cincinnati, Ohio, United States
- The Ohio State Univ. AIDS CRS, Columbus, Ohio, United States
- Pitt CRS, Pittsburgh, Pennsylvania, United States
Collaborators
Janssen Pharmaceuticals
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00000975 on ClinicalTrials.govOther trials for Histoplasmosis
Additional recruiting or active studies for the same condition.